Literature DB >> 23258598

Overview of human primary tumorgraft models: comparisons with traditional oncology preclinical models and the clinical relevance and utility of primary tumorgrafts in basic and translational oncology research.

David H Lum1, Cindy Matsen, Alana L Welm, Bryan E Welm.   

Abstract

Laboratory models that accurately replicate human tumor initiation and characteristics are integral to advancing knowledge in cancer research. However, comparative studies between commonly employed laboratory models and human tumors have demonstrated that some models have molecular and genomic alterations dissimilar to the cancer type they attempt to replicate. In contrast, several recent comparative studies suggest that because patient-derived tumors grown in mice maintain many of the important characteristics of the original tumor, they represent an important tool for the development of new cancer therapeutics. Detailed in this overview are the advantages and disadvantages of the most commonly used cancer models for mechanistic and therapeutic research, with an emphasis on the advances made in the production and use of patient-derived tumorgrafts.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23258598      PMCID: PMC3539738          DOI: 10.1002/0471141755.ph1422s59

Source DB:  PubMed          Journal:  Curr Protoc Pharmacol        ISSN: 1934-8282


  60 in total

1.  Human breast cancer responsive to androgen in long term tissue culture.

Authors:  M E Lippman; G Bolan; K Huff
Journal:  Nature       Date:  1975-11-27       Impact factor: 49.962

2.  Integration of chemotherapy into combined modality treatment of solid tumors. 1. The overall strategy.

Authors:  S K Carter; W T Soper
Journal:  Cancer Treat Rev       Date:  1974-03       Impact factor: 12.111

3.  In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice.

Authors:  K Morikawa; S M Walker; J M Jessup; I J Fidler
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

4.  A new animal model for human colon cancer metastasis.

Authors:  R S Bresalier; S E Raper; E S Hujanen; Y S Kim
Journal:  Int J Cancer       Date:  1987-05-15       Impact factor: 7.396

Review 5.  Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice.

Authors:  Annapoorni Rangarajan; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2003-12       Impact factor: 60.716

6.  Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.

Authors:  E Coezy; J L Borgna; H Rochefort
Journal:  Cancer Res       Date:  1982-01       Impact factor: 12.701

7.  Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice.

Authors:  R Giavazzi; D E Campbell; J M Jessup; K Cleary; I J Fidler
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

8.  Experimental nude mouse model of human colorectal cancer liver metastases.

Authors:  R Giavazzi; J M Jessup; D E Campbell; S M Walker; I J Fidler
Journal:  J Natl Cancer Inst       Date:  1986-12       Impact factor: 13.506

Review 9.  Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development.

Authors:  J K Peterson; P J Houghton
Journal:  Eur J Cancer       Date:  2004-04       Impact factor: 9.162

10.  Pharmacokinetic approach to rational therapeutic doses for human tumor-bearing nude mice.

Authors:  M Inaba; T Kobayashi; T Tashiro; Y Sakurai
Journal:  Jpn J Cancer Res       Date:  1988-04
View more
  14 in total

1.  Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies.

Authors:  Colton Hanna; Letty Kwok; Jessica Finlay-Schultz; Carol A Sartorius; Diana M Cittelly
Journal:  J Vis Exp       Date:  2016-11-30       Impact factor: 1.355

2.  Development and Evaluation of Transgenic Nude Mice Expressing Ubiquitous Green Fluorescent Protein.

Authors:  Srikanth Iyer; Shailendra Arindkar; Alaknanda Mishra; Kapil Manglani; Jerald Mahesh Kumar; Subeer S Majumdar; Pramod Upadhyay; Perumal Nagarajan
Journal:  Mol Imaging Biol       Date:  2015-08       Impact factor: 3.488

3.  Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis.

Authors:  H Bonsang-Kitzis; B Sadacca; A S Hamy-Petit; M Moarii; A Pinheiro; C Laurent; F Reyal
Journal:  Oncoimmunology       Date:  2015-06-24       Impact factor: 8.110

Review 4.  Patient-derived xenograft (PDX) models in basic and translational breast cancer research.

Authors:  Lacey E Dobrolecki; Susie D Airhart; Denis G Alferez; Samuel Aparicio; Fariba Behbod; Mohamed Bentires-Alj; Cathrin Brisken; Carol J Bult; Shirong Cai; Robert B Clarke; Heidi Dowst; Matthew J Ellis; Eva Gonzalez-Suarez; Richard D Iggo; Peter Kabos; Shunqiang Li; Geoffrey J Lindeman; Elisabetta Marangoni; Aaron McCoy; Funda Meric-Bernstam; Helen Piwnica-Worms; Marie-France Poupon; Jorge Reis-Filho; Carol A Sartorius; Valentina Scabia; George Sflomos; Yizheng Tu; François Vaillant; Jane E Visvader; Alana Welm; Max S Wicha; Michael T Lewis
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

5.  Person-to-Person Cancer Transmission via Allogenic Blood Transfusion.

Authors:  Eugen Molodysky; Ross Grant
Journal:  Asian Pac J Cancer Prev       Date:  2021-03-01

6.  Nonlinear mixed effects dose response modeling in high throughput drug screens: application to melanoma cell line analysis.

Authors:  Kuan-Fu Ding; Emanuel F Petricoin; Darren Finlay; Hongwei Yin; William P D Hendricks; Chris Sereduk; Jeffrey Kiefer; Aleksandar Sekulic; Patricia M LoRusso; Kristiina Vuori; Jeffrey M Trent; Nicholas J Schork
Journal:  Oncotarget       Date:  2017-12-15

7.  Targeting heterogeneity of adrenocortical carcinoma: Evaluation and extension of preclinical tumor models to improve clinical translation.

Authors:  Constanze Hantel; Igor Shapiro; Giada Poli; Costanza Chiapponi; Martin Bidlingmaier; Martin Reincke; Michaela Luconi; Sara Jung; Felix Beuschlein
Journal:  Oncotarget       Date:  2016-11-29

Review 8.  Recent technological advances in using mouse models to study ovarian cancer.

Authors:  Carrie Danielle House; Lidia Hernandez; Christina Messineo Annunziata
Journal:  Front Oncol       Date:  2014-02-13       Impact factor: 6.244

9.  Reversible inhibition of lysine specific demethylase 1 is a novel anti-tumor strategy for poorly differentiated endometrial carcinoma.

Authors:  Emily R Theisen; Snehal Gajiwala; Jared Bearss; Venkataswamy Sorna; Sunil Sharma; Margit Janat-Amsbury
Journal:  BMC Cancer       Date:  2014-10-09       Impact factor: 4.430

10.  Molecular dissection of the mechanism by which EWS/FLI expression compromises actin cytoskeletal integrity and cell adhesion in Ewing sarcoma.

Authors:  Aashi Chaturvedi; Laura M Hoffman; Christopher C Jensen; Yi-Chun Lin; Allie H Grossmann; R Lor Randall; Stephen L Lessnick; Alana L Welm; Mary C Beckerle
Journal:  Mol Biol Cell       Date:  2014-07-23       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.